SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-19-166345
Filing Date
2019-06-06
Accepted
2019-06-05 17:52:32
Documents
2
Effectiveness Date
2019-06-06

Document Format Files

Seq Description Document Type Size
1 DEFR14A d759387ddefr14a.htm DEFR14A 17864
2 GRAPHIC g759387g0606024220569.jpg GRAPHIC 6745
  Complete submission text file 0001193125-19-166345.txt   28435
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-36783 | Film No.: 19880887
SIC: 2834 Pharmaceutical Preparations